4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000017
Options or other derivatives
- EVP, Chf Clinical Develop Ofcr acquired 22,942 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-01-03 | Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) | +22,942 | $37.58 | 2033-01-02 | 22,942 | 22,942 | D |
Loading xslF345X03/edgardoc.xml…